Scribd Logo
Upload

Welcome to Scribd!

  • 16 views

    Drug Study Maf

    Uploaded by

    Sophia Marie
    This document summarizes information about the drug Linagliptin, including its drug class, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Linagliptin is a DPP-4 enzyme inhibitor used as an adjunct to improve glycemic control in type 2 diabetes. It works by inhibiting the DPP-4 enzyme and preventing the breakdown of incretin hormones. Nurses should monitor patients for hypoglycemia and hypersensitivity reactions and educate patients about reporting side effects.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Drug Study Maf

    Uploaded by

    Sophia Marie
    16 views5 pages
    This document summarizes information about the drug Linagliptin, including its drug class, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Linagliptin is a DPP-4 enzyme inhibitor used as an adjunct to improve glycemic control in type 2 diabetes. It works by inhibiting the DPP-4 enzyme and preventing the breakdown of incretin hormones. Nurses should monitor patients for hypoglycemia and hypersensitivity reactions and educate patients about reporting side effects.

    Original Title

    drug study maf.docx

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes information about the drug Linagliptin, including its drug class, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Linagliptin is a DPP-4 enzyme inhibitor used as an adjunct to improve glycemic control in type 2 diabetes. It works by inhibiting the DPP-4 enzyme and preventing the breakdown of incretin hormones. Nurses should monitor patients for hypoglycemia and hypersensitivity reactions and educate patients about reporting side effects.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    16 views5 pages

    Drug Study Maf

    Uploaded by

    Sophia Marie
    This document summarizes information about the drug Linagliptin, including its drug class, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Linagliptin is a DPP-4 enzyme inhibitor used as an adjunct to improve glycemic control in type 2 diabetes. It works by inhibiting the DPP-4 enzyme and preventing the breakdown of incretin hormones. Nurses should monitor patients for hypoglycemia and hypersensitivity reactions and educate patients about reporting side effects.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 5

    DRUG STUDY

    DRUG MECHANISM OF NURSING


    DRUG NAME INDICATIONS CONTRAINDICATIONS ADVERSE EFFECTS
    CLASS ACTION RESPONSIBILITIES
    Linagliptin Chemical Inhibits the As adjunct to Hypersensitivity to CNS: Headache Before:
    class: enzyme, dipeptidyl improve glycemic linagliptin or its
    Dipeptidyl peptidase-4, that control in type 2 components,
    Drug peptidase-4 degrades incretin diabetes mellitus ketoacidosis, type 1 CV: Hyperlipidemia, Know that linagliptin’s
    Availability: enzyme hormones diabetes mellitus hypertriglyceridemia hypersensitivity may be
    inhibitor responsible for exhibited through serious
    glucose elevation. adverse reactions such as
    Dosage: anaphylaxis, angioedema,
    EENT: Mouth ulceration,
    Therapeutic bronchial hyperreactivity,
    nasopharyngitis,
    exfoliative skin conditions, or
    class: stomatitis urtiaria. Monitor patient
    Antidiabetic
    closely for hypersensitivity
    reactions. If present, withhold
    ENDO: Hypoglycemia drug immediately, notify
    prescriber, and be prepared
    to administer emergency
    GI: Acute pancreatitis, care, as ordered.
    constipation, diarrhea

    During:
    GU: UTI

    ● Monitor patient closely


    MS: Arthralgia (may be for hypoglycemia,
    especially if another
    disabling and severe);
    antidiabetic drug, such
    back, extremity, or joint
    as insulin or a
    pain; myalgia sulfonylurea is used
    concomitantly.

    RESP: Bronchial ● Monitor the patient’s


    hyperreactivity, cough blood glucose level
    routinely to determine
    response to drug.
    SKIN: Localized skin Expect to check the
    exfoliation, rash, urticaria patient’s glycosylated
    hemoglobin every 3 to
    6 months or as ordered
    Other: Anaphylaxis, to evaluate long-term
    angioedema, elevated blood glucose control.
    uric acid, weight gain

    After:
    ● Urge patient to report
    evidence of
    hypoglycemia, such as
    anxiety, confusion,
    dizziness, excessive
    sweating, headache,
    and nausea.

    ● Encourage patient to
    carry hard candy or
    other simple sug
    Drug Study
    DRUG MECHANISM OF NURSING
    DRUG NAME INDICATIONS CONTRAINDICATIONS ADVERSE EFFECTS
    CLASS ACTION RESPONSIBILITIES
    Sulodexide Chemical thrombin inhibition Prophylaxis and ● Hypersensitivity GI: Nausea, vomiting, Before:
    class: is due to the treatment of towards vessel epigastralgia
    Drug Corticosteroid additive effect of vascular diseases due F, heparin ● Assess patients for
    Availability: s its components, with increased risk and heparin-like Local: pain, burn, signs
    namely, heparin of thrombosis products. hematoma at injection of bleeding and
    Dosage: Therapeutic cofactor II (HCII) including site hemorrhage (bleeding
    class: anti- catalysis by intermittent ● Diathesis gums; nosebleed;
    inflammatorie dermatan sulfate claudication, unusual bruising; black,
    s and antithrombin peripheral arterial ● Hemorrhagic tarry stools; hematuria;
    III catalysis by fast occlusive disease disease fall in hematocrit or
    moving heparin and post- blood pressure; guaiac-
    myocardial positive stools). Notify
    infarction. physician if these occur.

    During:

    ● Monitor patient for


    hypersensitivity
    reactions (chills, fever,
    urticaria). Report signs
    to physician

    After:
    ● Urge patient to report
    evidence of
    hypoglycemia, such as
    anxiety, confusion,
    dizziness, excessive
    sweating, headache,
    and nausea.

    ● Advise the patient to


    take the drug before
    meals. Swallow the
    capsules whole; do not chew,
    open, or crush them.

    You might also like